ephrin-a5 has been researched along with Brain Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
D'Agostino, R; Debinski, W; Ferluga, S; Herpai, DM; Tomé, CM | 1 |
Li, JJ; Liu, DP; Liu, GT; Xie, D | 1 |
2 other study(ies) available for ephrin-a5 and Brain Neoplasms
Article | Year |
---|---|
Simultaneous targeting of Eph receptors in glioblastoma.
Topics: Antineoplastic Agents; Apoptosis; Brain; Brain Neoplasms; Ephrin-A5; Glioblastoma; Humans; Immunotherapy; Immunotoxins; Protein Binding; Receptor Protein-Tyrosine Kinases; Receptor, EphA3; Single-Chain Antibodies; Tumor Cells, Cultured; Tumor Stem Cell Assay; Up-Regulation | 2016 |
EphrinA5 acts as a tumor suppressor in glioma by negative regulation of epidermal growth factor receptor.
Topics: Animals; Brain Neoplasms; Ephrin-A5; ErbB Receptors; Glioblastoma; Humans; Mice; Mice, Nude; Phosphorylation; Proto-Oncogene Proteins c-cbl; Signal Transduction; Tumor Suppressor Proteins; Ubiquitin | 2009 |